TMR Predicts Anxiety Disorders and Depression Treatment Market to Hike at CAGR 1.25% During 2014-2020
With anxiety disorders and depression becoming a substantial public health burden, efforts are increasingly afoot to reduce their impact. A large part of this endeavor entails the use of anxiolytics and antidepressants, which will augur well for the global anxiety disorders and depression treatment market. According to a new report published by Transparency Market Research, the global anxiety disorders and depression treatment market will log a 1.25% CAGR to go from its 2013 valuation of US$22.5 bn down to US$18.2...
View full press release